Understanding the Chemotherapy Drug Enfortumab Vedotin 認識化療藥品Enfortumab vedotin
2026/7/21
Enfortumab vedotin is an antibody–drug conjugate (ADC) that combines a monoclonal antibody with a small-molecule cytotoxic drug, specifically targeting and killing tumor cells. Clinically, it can be used alone or in combination with other drugs to treat locally advanced or metastatic urothelial carcinoma.